Clinical Trial Update: Plaque Regression and Progenitor Cell Mobilization With Intensive Lipid Elimination Regimen (PREMIER), Phase II [Phase 3]

View source ↗

Summary

Phase 3/Phase II trial investigating plaque regression and progenitor cell mobilization with an intensive lipid elimination regimen in acute coronary syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Snippet

Sponsor: VA Office of Research and Development | Conditions: Acute Coronary Artery Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2019-07-10